<--- Back to Details
First PageDocument Content
Western calligraphy / Character encoding / Swedish language / Danish language / Norwegian language / Diaeresis / Å / Darunavir / Emtricitabine/tenofovir/efavirenz / Latin script / Latin alphabet ligatures / Orthography
Date: 2013-10-15 13:14:19
Western calligraphy
Character encoding
Swedish language
Danish language
Norwegian language
Diaeresis
Å
Darunavir
Emtricitabine/tenofovir/efavirenz
Latin script
Latin alphabet ligatures
Orthography

#$%  , ,。

Add to Reading List

Source URL: www.info.gov.hk

Download Document from Source Website

File Size: 775,80 KB

Share Document on Facebook

Similar Documents

BMS_Gilead_Logo_FINAL.eps

BMS_Gilead_Logo_FINAL.eps

DocID: 1m38a - View Document

Patient Information ATRIPLA® (uh TRIP luh) Tablets ALERT: Find out about medicines that should NOT be taken with ATRIPLA. Please also read the section

Patient Information ATRIPLA® (uh TRIP luh) Tablets ALERT: Find out about medicines that should NOT be taken with ATRIPLA. Please also read the section "MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA." Generic name: efaviren

DocID: 1lg5I - View Document

This is an electronically controlled document. User is responsible to verify and use the current revision.  GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

DocID: 1azYS - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION   New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine

HIGHLIGHTS OF PRESCRIBING INFORMATION  New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine

DocID: 1ah6Z - View Document

Microsoft Word - FPC QHP Policy Guide Febdoc

Microsoft Word - FPC QHP Policy Guide Febdoc

DocID: 19ARO - View Document